Mid-Year Report

FIERCE, ISAKOWITZ & BLALOCK for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR. 2900 S. 1082 Biologics Patent Reform Pediatric Exclusivity Appropriations

LobbyistCovered position, as disclosed
WILLIAM KIRK BLALOCK N/A
KIRSTEN CHADWICK N/A
MICHAEL CHAPPELL N/A
SAMANTHA COOK N/A
DONALD L FIERCE N/A
KATHRYN BRADEN HUFFARD N/A
KATE HULL N/A
MARK WARREN ISAKOWITZ N/A
ALEIX JARVIS LD, SENATOR LINDSEY GRAHAM

Contacted: White House Office; SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 1082 (110th), H.R. 2900 (110th)

Medicare/Medicaid MMM

Medicare/Medicaid Biologics

LobbyistCovered position, as disclosed
WILLIAM KIRK BLALOCK N/A
KIRSTEN CHADWICK N/A
MICHAEL CHAPPELL N/A
SAMANTHA COOK N/A
DONALD L FIERCE N/A
KATHRYN BRADEN HUFFARD N/A
KATE HULL N/A
MARK WARREN ISAKOWITZ N/A
ALEIX JARVIS LD, SENATOR LINDSEY GRAHAM

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); White House Office; SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.